Ipamorelin/Tesamorelin 10mg

Dual peptide blend: Ipamorelin (5mg) + Tesamorelin (5mg) — GHS-R agonist paired with GHRH analog Two distinct GH-axis receptor targets in a single co-lyophilized vial For in vitro dual-mechanism GH-axis research only

$76.99 In stock

Research-Grade CompoundsManufactured to research-grade standards for laboratory research use only.

Discreet ShippingEvery order ships in plain, protective packaging.

In-House FulfillmentOrders are inspected, packed, and shipped directly by the Heritage Labs team.

SSL 256-bit Secure Checkout

Same-day dispatch on orders before 12:00 PM ET, Mon–Fri. Discreet, plain packaging.

In-House Fulfillment Orders are inspected, packed, and shipped directly by the Heritage Labs team.

View this compound’s Certificate of Analysis →

For laboratory research use only. Not for human or veterinary consumption. SKU IPTESA55.

Overview

Product details.

Ipamorelin / Tesamorelin Blend 5mg/5mg

Two peptides, two receptor systems, one vial. Ipamorelin is a selective ghrelin receptor (GHS-R) agonist — a pentapeptide that triggers GH release without touching cortisol or prolactin. Tesamorelin is a 44-amino-acid GHRH analog with a lipophilic trans-3-hexenoic acid cap that shields it from aminopeptidase degradation. They work through entirely different receptor mechanisms within the somatotropic axis, which is precisely the point of co-formulating them.

Research-Grade Compounds

Manufactured to research-grade standards for laboratory research use only.

Discreet Shipping

Every order ships in plain, protective packaging.

In-House Fulfillment

Orders are inspected, packed, and shipped directly by the Heritage Labs team.

Component breakdown

Ipamorelin (5mg)

Selective GHS-R agonist pentapeptide. CAS 170851-70-4. MW 711.85 g/mol. Characterized by Raun et al. as the first GH secretagogue with selectivity comparable to GHRH itself.

Tesamorelin (5mg)

Full-length GHRH analog (all 44 amino acids) with N-terminal lipophilic stabilization. CAS 218949-48-5. MW 5135.83 g/mol. A structurally different approach to GHRH receptor agonism than the truncated, tetra-substituted CJC-1295.

Why this pairing

GHRH receptor activation and ghrelin receptor signaling converge on pituitary somatotrophs through complementary cascades. Preclinical literature has characterized how these two inputs interact — the GHRH pathway through cAMP/PKA, the GHS-R pathway through PLC/IP3/calcium. Studying both under identical experimental conditions in a single reconstitution eliminates variability from separate preparations.

Specifications

Content	5mg Ipamorelin + 5mg Tesamorelin per vial
Format	Co-lyophilized powder
Testing	, both components verified

Storage

Lyophilized: -20°C
Reconstituted: 2-8°C, use within 30 days

For laboratory research use only. Not for human or veterinary use.

For laboratory research use only. Not for human or veterinary use. This product is not a drug or supplement and is not intended to diagnose, treat, cure, or prevent any disease.

FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.